The US Food and Drug Administration is postponing a highly anticipated meeting of expert advisers to discuss COVID-19 vaccines for children six months to five years old.
That will delay access to a COVID-19 vaccine for the youngest children.
US Correspondent Rachel Silverman has details.
IN: Pfizer and
OUT:SOC
DUR: 37
GENERIC: http://www.fsnradionews.com/feeds/0211kids-rs-generic.mp3